Dengue Fever Vaccines and Vaccinations available in Cheltenham

Your one stop Vaccination Clinic

Dengue Fever Vaccine

We provide a full range of Dengue Fever travel vaccinations and medication

Dengue Fever

Dengue fever, a viral illness transmitted primarily by Aedes mosquitoes, is a growing global health concern. With an estimated 390 million infections annually, it poses a significant threat to human populations in tropical and subtropical regions. This arbovirus, belonging to the Flaviviridae family, is characterised by sudden onset of fever, severe joint and muscle pain, rash, and other flu-like symptoms.

View all vaccine prices

Vaccination Pricing

£120 Per dose
£240 Per Course

Signs & Symptoms

While most cases result in mild illness, some individuals may experience life-threatening complications, such as;

Dengue haemorrhagic fever
Dengue shock syndrome
Organ failure or even death

James Pharmacy & Travel Clinic

General Contact & Travel Vaccination

Tel: 01242 522 880

Email: cheltenhamtravelclinic@raylane.co.uk

19 St Georges Road, Cheltenham GL50 3DT

Book this clinic

Wymans Brook Pharmacy & Travel Clinic

General Contact & Travel Vaccination

Tel: 01242 221 988

Email: cheltenhamtravelclinic@raylane.co.uk

Unit 1, Windyridge Rd, Cheltenham GL50 4RA

Book this clinic

The Vaccination

Ages (Years)	Doses Required	Schedule	Time before travel	Boost required at
4 years and over	2	0 & 3 months	2 weeks or more	–

What is Dengue Fever?

Dengue fever is a viral infection spread by the bite of infected Aedes mosquitoes, which are most active during the daytime. It’s common in tropical and subtropical regions including parts of Asia, Africa, Central and South America, and the Caribbean. Dengue can range from a mild flu-like illness to a severe, potentially life-threatening condition known as dengue haemorrhagic fever. Travellers visiting these regions—especially during the rainy season or staying in rural areas—are at increased risk of exposure.

How does it spread and how to prevent it?

Dengue fever is primarily transmitted to humans through the bite of infected Aedes mosquitoes, most commonly the Aedes aegypti species. The process of catching dengue fever begins when a female Aedes mosquito, already infected with the dengue virus, bites an individual. These mosquitoes are typically active during the day, with peak activity in the early morning and late afternoon. When an infected mosquito feeds on a person’s blood, it injects the dengue virus into the bloodstream. Once inside the human body, the virus begins to replicate and spread.

It’s important to note that dengue fever cannot be directly transmitted from one person to another. Instead, the virus relies on the mosquito vector to continue its transmission cycle. Prevention includes avoiding mosquito bites by using insect repellent, wearing long sleeves, and staying in air-conditioned or screened areas. A vaccine (Qdenga) is now available. In regions where dengue is endemic, these preventative measures are crucial to minimising the risk of contracting this potentially debilitating disease.

What are the symptoms of dengue fever?

Symptoms usually appear 4 to 10 days after being bitten by an infected mosquito. The illness often begins with a sudden high fever, accompanied by severe headache, pain behind the eyes, muscle and joint pain, nausea, and a skin rash. It’s sometimes referred to as “breakbone fever” due to the intense joint and muscle pain it causes. In more serious cases, dengue can progress to bleeding, low blood pressure, and organ damage, particularly in people who have had previous dengue infections. Severe dengue is a medical emergency and requires hospital care.

How long does the vaccine last?

There are a couple of dengue fever vaccines, including Dengvaxia (CYD-TDV) and the newer Qdenga (TAK-003). Protection typically begins within a few weeks after completing the vaccination schedule. For Dengvaxia, which is recommended only for individuals aged 9–45 who have previously had dengue, protection can last for at least six years, with ongoing research examining longer-term effectiveness. Qdenga, approved more recently in some regions, is suitable for people aged 4 and older, regardless of previous dengue exposure. After the full two-dose course of Qdenga, administered three months apart, protection is expected to last for several years, though long-term booster guidance is still being studied. Duration may vary depending on age, prior exposure, and local transmission risk, and boosters may be recommended in the future for extended protection in endemic areas.

Countries I need the vaccine for

The vaccine is recommended for travellers to dengue-endemic countries in South and Southeast Asia, the Caribbean, Central and South America, and parts of Africa and the Pacific Islands.

Side effects of vaccination

Side effects of the Qdenga vaccine are generally mild and may include pain or swelling at the injection site, tiredness, low-grade fever, or headache. These symptoms are short-lived and much less disruptive than the disease itself. There is currently no cure for dengue once infected, which makes vaccination and mosquito bite prevention especially important.

If you’re planning to travel to a dengue-risk area, book your dengue vaccination with us. Our pharmacy team is here to offer expert advice, personalised travel health guidance, and quick access to the protection you need for safe and healthy travel.